Evidence map›Paper›PMID 31487687›Full record

ArticleJournal of the National Comprehensive Cancer Network : JNCCN2019

Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology.

Al B Benson, Alan P Venook, Mahmoud M Al-Hawary, Mustafa A Arain, Yi-Jen Chen, Kristen K Ciombor, Stacey A Cohen, Harry S Cooper, Dustin A Deming, Ignacio Garrido-Laguna and 27 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of the National Comprehensive Cancer Network : JNCCN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04671511 (Sentinel Node Biopsy and Targeted Axillary Dissection in Node-Positive Breast Cancer Patients With Clinically Negative Axilla), which is not on this map. Cited by 182 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
182citing papers in PubMed, 6 pooled it
24.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04671511 narecruitingnot on this mapstarted 2021, after this paper: background citation

Sentinel Node Biopsy and Targeted Axillary Dissection in Node-Positive Breast Cancer Patients With Clinically Negative Axilla

TypeinterventionalSponsorJewish General HospitalRan2021 to 2026Enrolled98ConditionsBreast Cancer Female, Early-stage Breast Cancer, Lymph Node Metastases, Axillary MetastasesArmsTargeted Axillary Dissection, Ultrasound of the axilla
3 · Its place in the literature

Who cites it

182 citing papers in PubMed, 6 syntheses or guidelines pooled it, 256 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Music interventions can alleviate cancer-related fatigue: a metaanalysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

122 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 3 countries.

Al B BensonRobert H. Lurie Comprehensive Cancer Center of Northwestern University.
Alan P VenookUCSF Helen Diller Family Comprehensive Cancer Center.
Mahmoud M Al-HawaryUniversity of Michigan Rogel Cancer Center.
Mustafa A ArainUCSF Helen Diller Family Comprehensive Cancer Center.
Yi-Jen ChenCity of Hope National Medical Center.
Kristen K CiomborVanderbilt-Ingram Cancer Center.
Stacey A CohenFred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
Harry S CooperFox Chase Cancer Center.
Dustin A DemingUniversity of Wisconsin Carbone Cancer Center.
Ignacio Garrido-LagunaHuntsman Cancer Institute at the University of Utah.
Jean L GremFred & Pamela Buffett Cancer Center.
Sarah E HoffeMoffitt Cancer Center.
Joleen HubbardMayo Clinic Cancer Center.
Steven HuntSiteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
Ahmed KamelO'Neal Comprehensive Cancer Center at UAB.
Natalie KirilcukStanford Cancer Institute.
Smitha KrishnamurthiCase Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
Wells A MessersmithUniversity of Colorado Cancer Center.
Jeffrey MeyerhardtDana-Farber/Brigham and Women's Cancer Center.
Eric D MillerThe Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
Mary F MulcahyRobert H. Lurie Comprehensive Cancer Center of Northwestern University.
Steven NurkinRoswell Park Comprehensive Cancer Center.
Michael J OvermanThe University of Texas MD Anderson Cancer Center.
Aparna ParikhMassachusetts General Hospital Cancer Center.
Hitendra PatelUC San Diego Moores Cancer Center.
Katrina S PedersenSiteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
Leonard B SaltzMemorial Sloan Kettering Cancer Center.
Charles SchneiderAbramson Cancer Center at the University of Pennsylvania.
David ShibataThe University of Tennessee Health Science Center.
John M SkibberThe University of Texas MD Anderson Cancer Center.
Constantinos T SofocleousMemorial Sloan Kettering Cancer Center.
Elena M StoffelUniversity of Michigan Rogel Cancer Center.
Eden Stotsky-HimelfarbThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Christopher G WillettDuke Cancer Institute; and.
Alyse Johnson-ChillaNational Comprehensive Cancer Network.
Kristina M GregoryNational Comprehensive Cancer Network.
Lisa A GurskiNational Comprehensive Cancer Network.
Cancer Institute (WIA) · INNational Comprehensive Cancer NetworkBarnes-Jewish Hospital · USMemorial Sloan Kettering Cancer Center · USRobert H. Lurie Comprehensive Cancer Center of Northwestern UniversityThe University of Texas MD Anderson Cancer Center · USUCSF Helen Diller Family Comprehensive Cancer Center · USUniversity of Michigan–Ann Arbor · USBreast Cancer Research Foundation · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZACity Of Hope National Medical Center · USDana-Farber Brigham Cancer Center · USFox Chase Cancer Center · USHuntsman Cancer Institute · USMassachusetts General Hospital · USMoffitt Cancer Center · USO'Neal Comprehensive Cancer CenterSidney Kimmel Comprehensive Cancer Center · USSusan Thompson Buffett Foundation · USThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · US

Funding

Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
NCI NIH HHS K12 CA090625
6 · The paper itself

Abstract

Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that has increased in incidence across recent years. Often diagnosed at an advanced stage, outcomes for SBA are worse on average than for other related malignancies, including colorectal cancer. Due to the rarity of this disease, few studies have been done to direct optimal treatment, although recent data have shown that SBA responds to treatment differently than colorectal cancer, necessitating a separate approach to treatment. The NCCN Guidelines for Small Bowel Adenocarcinoma were created to establish an evidence-based standard of care for patients with SBA. These guidelines provide recommendations on the workup of suspected SBA, primary treatment options, adjuvant treatment, surveillance, and systemic therapy for metastatic disease. Additionally, principles of imaging and endoscopy, pathologic review, surgery, radiation therapy, and survivorship are described.

Indexed as

Practice Guidelines as TopicAdenocarcinomaCombined Modality TherapyDiagnosis, DifferentialHumansIntestinal NeoplasmsIntestine, SmallNeoplasm StagingRisk FactorsSurvivorshipTreatment OutcomeWatchful Waiting

Identifiers

PMID31487687
PMCPMC10191182
OpenAlexW2971594300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.